Australia's Osteopore hits nine-month high on Hong Kong expansion

Osteopore

22/01/2026 24:42

** Shares of Australia's Osteopore OSX.AX jump 40% to A$0.028, their highest level since mid-April 2025

** Regenerative medicine co expands its orthopaedic business into Hong Kong via an exclusive distribution agreement with MontsMed Hong Kong Company

** Business will initially focus on the orthopaedic trauma reconstruction market, a segment where co's devices have the highest likelihood of application

** Shares have more than quadrupled in value, YTD

 (Reporting by Shruti Agarwal in Bengaluru)

 ((Shruti.Agarwal@thomsonreuters.com))